 |
| |
The Economist
Hale and Healthy
BusinessWeek
“Nonprofit Drugs for the Poor”
» more articles
|
|
 |
|
|
 |
| |
Elimination of Kala-azar from endemic countries in the South-East Asia Region
Geneva/New Delhi, (WHO) - The Health Ministers of three Member States of WHO’s South-East Asia Region, India, Nepal and Bangladesh, today signed a Memorandum... Read more
|
|
 |
|
 |
| |
We're growing and looking for talented industry professionals.
Read more
|
|
|
|
|
|
|
|
 |
|
 |
Paromomycin Receives Orphan Drug Status by FDA and EMEA
OneWorld Health has received Orphan Drug Designation from the two leading regulatory agencies in the world for paromomycin to treat visceral leishmaniasis (VL). Read more
|
|
|
 |
OneWorld Health Receives Nominations for Pharmaceutical Achievement
Victoria Hale and OneWorld Health were selected as finalists for the Emerging Executive of the Year Award and the Social Responsibility Award, respectively.
Read more
|
|
|
|
» more announcements |
|
 |
|
 |
OneWorld Health Hosts Booth
at BIO 2005
The company will host a booth at the Biotechnology Industry Organization’s annual international convention in June. Read more
|
|
|
| |
» more events |
|
 |
|
 |
Donor Spotlight
OneWorld Health's unique and diverse community of supporters continues to grow. Read more
|
|
|
|
 |
Latest Gifts
Your support enables us to grow, to seek new opportunities and to maintain our leadership as social entrepreneurs in global health.
Read more
|
|
|
|
|
|
|
|
